108
Views
2
CrossRef citations to date
0
Altmetric
Review

Optogenetics in preclinical neuroscience and psychiatry research: recent insights and potential applications

, &
Pages 1369-1379 | Published online: 22 Jul 2014

Figures & data

Table 1 Summary of noteworthy opsin proteins commonly used in optogenetic research

Table 2 Contribution of various brain regions and circuits to the expression of depression-like symptoms

Figure 1 Schematic depiction of brain circuits controlling anxiety.

Notes: Recent studies utilizing optogenetic approaches have implicated discrete populations of neurons and neural projections in anxiety disorders. Circles represent populations of neurons that have been targeted with optogenetic manipulations. Anxiogenic populations are represented in red, anxiolytic in blue, and populations producing no effect in white. Experiments in which opsins were targeted to genetically-defined cell populations are indicated by the relevant cell type listed within the circle. The presence or absence of projections from these neurons (circles) in the figure indicates whether the represented experiment targeted optical manipulations at terminals or cell bodies, respectively.
Abbreviations: BLA, basolateral amygdala; BNST, bed nucleus of the stria terminalis; CEA, central nucleus of the amygdala; CRF R2, corticotropin-releasing factor receptor 2; D1R, dopamine receptor D1; GABA, gamma-aminobutyric acid; Glu, glutamate; HIPP, hippocampus; hypothal, hypothalamus; LS, lateral septum; mPFC, medial prefrontal cortex; oxy, oxytocin; VTA, ventral tegmental area.
Figure 1 Schematic depiction of brain circuits controlling anxiety.